2Darblade B, Pendaries C, Krust A, et al. Estradiol alters nitric oxide production in the mouse aorta through the alpha, but not beta, estrogen receptor[J]. Circ Res, 2002, 90(4):413
4Dubey RK, Jackson EK, Keller PJ, et al. Estradiol metabolites inhibit endothelin synthesis by an estrogen receptor-independent mechanism [J]. Hypertension, 2001, 37:640
5BA ZF, LU A, Shimizu T, et al. 17beta-Estradiol modulates vasoconstriction induced by endothelin-1 following trauma-hemorrhage [J]. Am J Physiol Heart Circ Physiol, 2007, 292(1):H245
6Ling S, Deng G, Ives HE, et al. Estrogen inhibits mechanical strain-induced mitogenesis in human vasculars mooth muscle cells via down-regulation of Sp1[J]. Cardiovasc Res,2001,50(1):108
7Kaplan B, Srinivas TR, MeierKriesche HU. Factors associated with long-term renal allograft survival[J]. The Drug Monit,2002,24(1):36
8Fertmann J, Zweier JL, WEI G. Nitric oxide and peroxynitrite in postischemic myocardium[J]. Antioxid Redox Signal,2001,3(1):11
9Land WG. The role of postischemic reperfusion injury and other nonantigen-dependent inflammatory pathways in transplantation[J]. Transplantation,2005,79(5):505
10Eckhoff DE, Bilbao G, Frenette L, et al. 17-Beta-estradiol protects the liver against warm ischemia/reperfusion injury and is associated with increased serum nitric oxide and decreased tumor necrosis factoralpha[J]. Surgery,2002,132(2):302
二级参考文献11
1[1]Lobo RA.Treatment of the postmenopausal women:basic and clinical aspects.2nd ed.Philadelphia,USA:Lippincott Williams & Wilhins,1999.331
2[2]Grady D.Cardiovascular disease outcomes during 6.8 years of hormone therapy for heart and estrogen/progestin replacement study follow-up (HERS Ⅱ).JAMA,2002, 288: 49
3[3]Hulley S, Grady D, Bush T,et al.Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA,1998, 280:605
4[4]Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women principal results from the Women's Health Initiative Randomized Controlled Trial. JAMA,2002, 288:321
6White E,Hildemann WH,Mullen Y.Chronic kidney allograft reactions in rats[].Transplantation.1969
7Sack MN,Rader DJ,Cannon RO.Oestrogen and inhibition of oxidation of low-density lipoproteins in postmenopausal women[].The Lancet.1994
8Solez K,Axelsen RA,Benediktsson H,et al.International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology[].Kidney International.1993
